According to NGM Biopharmaceuticals's latest financial reports the company's total assets are S$0.22 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | S$0.22 B | -45.88% |
2022-12-31 | S$0.41 B | -24.24% |
2021-12-31 | S$0.54 B | 24.97% |
2020-12-31 | S$0.43 B | -15.12% |
2019-12-31 | S$0.51 B | 52.55% |
2018-12-31 | S$0.33 B | 0.97% |
2017-12-31 | S$0.33 B | -16.95% |
2016-12-31 | S$0.40 B |